Transcriptome Analysis
If you're in search of answers regarding your specific medical condition and the best treatment options available for your unique physiology, you've found the right place. [...]
If you're in search of answers regarding your specific medical condition and the best treatment options available for your unique physiology, you've found the right place. [...]
Using Transcriptome to Accurate Disease Diagnosis, Prognosis, Severity, Treatment, and Adverse Reaction Prediction The identification of biomarkers plays a crucial role in assessing disease accuracy. Transcriptome biomarkers (gene expression [...]
Published: 30 December 2022 Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 disease Contributors: Mohamad Ammar Ayass, Trivendra Tripathi, Natalya Griko, Victor Pashkov, [...]
We need donors that are 18 and older to establish the ranges for a new assay to detect 65 cytokines from serum samples. The assay is one of a kind [...]
Ayass BioScience, LLC participated in Annual Meeting of The American Association of Immunologists in Oregon Convention Center Portland, Oregon, May 6-10 2022.
The Ayass Bioscience family is celebrating its sixth anniversary this year. The company has grown over the years from the dreams of our founder and CEO, Dr. Ayass, into one [...]
Testing for COVID-19 has gone up significantly in the last month, and consequently positive cases have risen as well and more Omicron variants were identified at our laboratory. Given the [...]
The Texas State Health Department has confirmed the findings of a Ayass BioScience, LLC laboratory that detected two North Texas cases of the omicron variant.
Ayass BioScience, LLC has detected the first two cases of the OMICRON variant in the DFW Metroplex using Next Generation Sequencing (NGS). This is a part of our [...]
People age 18 years and older who received Pfizer-BioNTech, Moderna COVID-19 or Johnson & Johnson’s Janssen vaccines may get a booster (According to CDC). You can make an appointment Now.